Zhitong Technology Secures Tens of Millions in Series A+ Funding Led by Hetang Venture Capital to Advance Global Registration and Commercialization of Surgical Microscopes

Investment Circle (ID: pedaily2012) August 18 News,Recently, Jiaxing AINNOVI Technology Co., Ltd. (hereinafter referred to as "AINNOVI") announced the completionTens of Millions of Yuan in Series A+ RoundFinancing. This round of financing was led byTusPark VenturesExclusiveInvestmentWinX Capital serves as the exclusive financial advisor once again. The funds from this round of financing will be mainly used for the domestic and overseas registration applications and market promotion of the full range of surgical and ophthalmic surgical microscopes.

AINNOVI was founded in 2020. The founding team started with cutting-edge research led by an academician from Tsinghua University, establishing a solid foundation in the field of stereoscopic vision. They completed a major instrument development project funded by the National Natural Science Foundation of China in collaboration with the team from the General Hospital of the People's Liberation Army, accumulating multiple core achievements in computational microscopic imaging and implementing their transformation. The company focuses on the research and development of innovative technologies for visual imaging, intelligent perception, and decision support in microsurgical scenarios. It aims to build a product portfolio featuring a new generation of digital surgical microscopes and intelligent clinical solutions, aspiring to become an industry leader and global provider that empowers the advancement of precision surgery.

AINNOVI, under its proprietary brand AINNOVI®, has rapidly launched 6 high-end microscopic imaging and intelligent products across 3 categories, leading the mid-to-high-end surgical microscope industry in China. The advanced 3D external visualization microscope upgrade product obtained a Class II Innovative Medical Device Registration Certificate in China, addressing the shortcomings of traditional optical surgical microscopes in external visualization while fulfilling the upgrade needs of existing traditional optical surgical microscopes in medical institutions. In addition to forming commercial partnerships with leading microscope brands and completing installations in over a hundred hospitals in China, the company has also achieved overseas (European) sales after obtaining CE certification.

AINNOVIFounder Shao Hang stated:AINNOVI originated from a national project of medical-engineering collaboration, utilizing imaging and intelligent technologies to explore the next-generation form of surgical microscopes, promoting the digital and intelligent development of the industry. AINNOVI will actively leverage its leading technological advantages in microscopic external visualization to become a Chinese expert in microscopic external visualization technology, contributing to the localization of mid-to-high-end surgical microscopes in China and adding Chinese strength to the global technological advancement of the surgical microscope industry.

TusPark Ventures' Managing Director Dai Chen stated:AINNOVI is an outstanding representative case born from the "integration of medicine and engineering" between Tsinghua University's technology and the medical needs of the PLA General Hospital, representing China’s high level and internationally leading advantage in the field of medical stereoscopic imaging technology. The company leads the transformation of microscopic surgery from traditional "pure optics" to "optics + digitalization + intelligence," promoting 3D external visualization as an important development trend in microscopic surgical imaging. At the same time, with its full-chain independent development capabilities and long-term accumulation in stereoscopic vision imaging technology, it has gained widespread acclaim and application in clinical circles. We are optimistic about AINNOVI’s technical strength and development prospects in the field of microscopic surgery, and we look forward to AINNOVI becoming a global leader and a "source of national pride" in the 3D external visualization microscopic surgery field.

WinX Capital's founding partner Guowen Zou stated:AINNOVI's Microscopic External Vision Product, with 4K ultra-high-definition resolution and 3D stereoscopic imaging technology, provides doctors with a clearer and more three-dimensional surgical view. By facing the display screen directly, it assists ophthalmologists, spinal surgeons, and other multi-department doctors in performing more precise surgical operations, leading the development and technological innovation of the microscopic external vision industry. We are honored that WinX Capital has continuously served as AINNOVI's exclusive financial advisor, and we look forward to the company growing into a leading enterprise in the mid-to-high-end microscope sector in China and even globally.